Salmeterol is named as an intervention in 2 current clinical trials in our Denmark register. 2 are recruiting patients now. All registered phases are Not applicable. The lead sponsor is University of Copenhagen. The most-studied condition is Healthy.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Muscle Anabolic Response to ฮฒ2-adrenergic Stimulation With Increased Amino Acid Availability.
NCT06654986 · ClinicalTrials.gov ↗ · Healthy
|
Not applicable | Recruiting | University of Copenhagen | Denmark |
|
Salmeterol Effect on Exercise Performance
NCT06655012 · ClinicalTrials.gov ↗ · Healthy
|
Not applicable | Recruiting | University of Copenhagen | Denmark |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
The same active substance in our other registers, matched by its exact name. Each entry links to the register record it comes from.
4 single-substance products containing Salmeterol on the HPRA medicines list.
No entry for Salmeterol in the EMA, FDA or German BfArM shortage lists we track.
| Lead sponsor | Trials |
|---|---|
| University of Copenhagen | 2 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Denmark | 2 | 2 |
A trial with sites in more than one country appears in each of those registers.
2 current trials in our Denmark register name Salmeterol as a drug or biological intervention, as of the registry sync on 27 September 2026. Completed and withdrawn studies are not counted.
Yes. 2 of the 2 trials are recruiting: 2 with sites in Denmark. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
The lead sponsor is University of Copenhagen. The number in brackets is how many trials each organisation leads.
Yes. The HPRA medicines list includes 4 single-substance products containing Salmeterol, for example Serevent Diskus, 50 micrograms per metered dose, inhalation powder, pre-dispensed (GlaxoSmithKline (Ireland) Limited). A licence does not mean a product is currently marketed or reimbursed; see each product's record.
Not in the lists we track: Salmeterol has no entry in the EMA, FDA or German BfArM shortage registers as of their latest sync.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Salmeterol works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records โ it is not written from memory, and nothing here describes how Salmeterol works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Salmeterol (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 27 Sep 2026.